Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Cash Flow Reinvestment Rate
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Cash Flow Reinvestment Rate of 1.83x as of September 2025, reinvesting CN¥72.46 Million (capex CN¥72.46 Million ) from operating cash flow of CN¥39.68 Million. Explore reinvestment intensity of Xizang Haisco Pharmaceutical Group Co Lt to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Xizang Haisco Pharmaceutical Group Co Ltd across 17 annual periods. Also explore how large is Xizang Haisco Pharmaceutical Group Co Lt's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2024)
Year-by-year capital reinvestment analysis for Xizang Haisco Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see 002653 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.24x | CN¥548.28 Million | CN¥442.05 Million | CN¥440.65 Million | ▼ -28.0% |
| 2023 | 1.72x | CN¥774.20 Million | CN¥449.58 Million | CN¥391.01 Million | ▼ -81.1% |
| 2022 | 9.09x | CN¥859.79 Million | CN¥94.55 Million | CN¥700.17 Million | ▼ -78.1% |
| 2021 | 41.47x | CN¥1.48 Billion | CN¥35.80 Million | CN¥702.94 Million | ▲ +879.6% |
| 2020 | 4.23x | CN¥873.05 Million | CN¥206.21 Million | CN¥601.72 Million | ▲ +440.7% |
| 2019 | 0.78x | CN¥598.43 Million | CN¥764.26 Million | CN¥582.68 Million | ▼ -10.4% |
| 2018 | 0.87x | CN¥413.11 Million | CN¥472.61 Million | CN¥351.98 Million | ▼ -31.4% |
| 2017 | 1.27x | CN¥499.13 Million | CN¥391.81 Million | CN¥393.26 Million | ▲ +144.9% |
| 2016 | 0.52x | CN¥221.61 Million | CN¥426.11 Million | CN¥208.24 Million | ▼ -21.9% |
| 2015 | 0.67x | CN¥295.16 Million | CN¥443.03 Million | CN¥283.68 Million | ▲ +42.6% |
| 2014 | 0.47x | CN¥234.86 Million | CN¥502.57 Million | CN¥234.86 Million | ▲ +62.0% |
| 2013 | 0.29x | CN¥163.98 Million | CN¥568.41 Million | CN¥163.98 Million | ▲ +7.0% |
| 2012 | 0.27x | CN¥125.30 Million | CN¥464.75 Million | CN¥125.30 Million | ▼ -40.3% |
| 2011 | 0.45x | CN¥117.72 Million | CN¥260.79 Million | CN¥117.72 Million | ▲ +104.9% |
| 2010 | 0.22x | CN¥80.95 Million | CN¥367.38 Million | CN¥80.95 Million | ▲ +237.9% |
| 2009 | 0.07x | CN¥24.01 Million | CN¥368.21 Million | CN¥24.01 Million | ▼ -83.5% |
| 2008 | 0.40x | CN¥37.38 Million | CN¥94.45 Million | CN¥37.38 Million | — |